DAB389-MSH

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDAB389-MSH
Drug Alias NameMSH toxin (Ligand)MSH toxin (Seragen/Ligand)MSH fusion toxin (Seragen)antimelanoma chimaeraDAB389-MSH
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMelanocortin receptor agonists
TargetsMelanocortin receptor
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeragen IncLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A